Brain tumor location may predict thinking and movement issues
NCT ID NCT04463979
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how the location of a tumor in the cerebellum (the part of the brain that controls balance and coordination) affects a person's thinking and movement skills before and after surgery. Researchers will follow 66 adults with brain tumors, testing their cognition and motor abilities using exams and brain scans. The goal is to better understand which brain areas are linked to these functions, which could help guide future treatments and recovery plans.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors predict and manage cognitive and motor problems in patients with cerebellar tumors, leading to better surgical planning and recovery.
- What could go wrong
- This is an observational study with only 66 participants, so results may not apply to everyone. It does not test a new treatment, so direct patient benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- Digital tests may offer a new way to track brain health in tumor patients
- Mapping the hidden toll of brain radiation on young minds
- Scientists create detailed brain maps to protect language during surgery
- Could a cancer drug shrink recurrent brain tumors?
- Engineered immune cells target deadly brain tumors in children